Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature

2007 ◽  
Vol 18 (8) ◽  
pp. 973-976 ◽  
Author(s):  
Francesc Cobo ◽  
Guillem De Celis ◽  
Arturo Pereira ◽  
Xavier Latorre ◽  
Jaume Pujadas ◽  
...  
2020 ◽  
Vol 4 (8) ◽  
pp. 1756-1759
Author(s):  
Maverick Chan ◽  
William K. Silverstein ◽  
Anna Nikonova ◽  
Katerina Pavenski ◽  
Lisa K. Hicks

Key Points Bendamustine can cause severe autoimmune hemolytic anemia (AIHA), which may require plasma exchange and aggressive immunosuppression. Bendamustine-induced AIHA can be delayed, and many, but not all, cases report prior exposure to fludarabine.


2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Ian Holmes ◽  
Nathaniel Berman ◽  
Vinicius Domingues

Phenazopyridine is a commonly used urinary analgesic available throughout the United States. Ingestion of large quantities can lead to methemoglobinemia, hemolytic anemia, jaundice, and acute renal failure. We report a case of a 78-year-old male with previously normal renal function who developed acute renal failure and jaundice without methemoglobinemia or hyperbilirubinemia after taking nearly 8 g of phenazopyridine over the course of 4 days. Initially presenting with oliguria, the urine output began to increase by day 2 of his admission, and the creatinine peaked 11 days after he began taking phenazopyridine, and he was discharged safely soon after. To our knowledge, this is the first such case of renal failure and jaundice without methemoglobinemia or hemolytic anemia in an adult patient with normal renal function.


2005 ◽  
Vol 5 (4) ◽  
pp. 283-286 ◽  
Author(s):  
Vanita Noronha ◽  
Barbara Burtness ◽  
John Murren ◽  
Thomas P. Duffy

1991 ◽  
Vol 13 (4) ◽  
pp. 445-447 ◽  
Author(s):  
F. Tavarela Veloso ◽  
J. Fraga ◽  
J. Carvalho ◽  
L. M. Dias ◽  
M. Ceu Salgado

Sign in / Sign up

Export Citation Format

Share Document